• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树状聚合物作为一种新型潜在的 siRNA 经皮给药载体:树突状聚合物与脂质体递送 TNF-α siRNA 的比较研究。

Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.

机构信息

Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad 500037, India.

Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Poland.

出版信息

Int J Pharm. 2018 Oct 25;550(1-2):240-250. doi: 10.1016/j.ijpharm.2018.08.024. Epub 2018 Aug 27.

DOI:10.1016/j.ijpharm.2018.08.024
PMID:30165098
Abstract

Topical delivery of siRNA is challenging task due to complex barrier property of stratum corneum and cationic lipid based carriers have been widely explored for this purpose due to improved permeation through skin. For gene delivery application, dendrimers are considered as efficient carrier due to their cationic nature and well-defined surface groups. However, they are not well explored for topical delivery. This work compares the suitability of PAMAM dendrimer with DOTAP liposome for topical delivery of siRNA against TNF-α. The particle size, zeta potential and entrapment efficiency of dendriplex were 99.80 ± 1.80 nm, 13.40 ± 4.84 mV and 98.72 ± 2.02% whereas for lipoplex were 174.80 ± 0.80 nm, 29.96 ± 0.51 mV and 94.99 ± 5.01% respectively. Both the formulations were stable in serum and in the presence of RNAse. TNF-α is inflammatory cytokine, hence the in vivo efficacy of developed formulations was determined using psoriatic plaque model. Results suggested improved phenotypic and histopathological features and reduced levels of IL-6, TNF-α, IL-17 and IL-22 for dendriplex and lipoplex treated groups in comparison to Imiquimod treated group. These findings suggest that dendrimer can be a potential carrier for topical gene delivery.

摘要

由于角质层的复杂屏障特性,siRNA 的局部递药是一项具有挑战性的任务,因此,由于经皮渗透得到改善,阳离子脂质载体已被广泛用于该目的。对于基因传递应用,由于其阳离子性质和明确的表面基团,树枝状聚合物被认为是有效的载体。然而,它们在局部递药方面的研究并不充分。这项工作比较了 PAMAM 树枝状聚合物与 DOTAP 脂质体用于局部递送针对 TNF-α 的 siRNA 的适用性。树枝状聚合物的粒径、Zeta 电位和包封效率分别为 99.80±1.80nm、13.40±4.84mV 和 98.72±2.02%,而脂质体的粒径、Zeta 电位和包封效率分别为 174.80±0.80nm、29.96±0.51mV 和 94.99±5.01%。两种制剂在血清中和 RNAse 存在下均稳定。TNF-α 是一种炎症细胞因子,因此,使用银屑病斑块模型确定了所开发制剂的体内疗效。结果表明,与咪喹莫特治疗组相比,树枝状聚合物和脂质体治疗组的表型和组织病理学特征得到改善,并且 IL-6、TNF-α、IL-17 和 IL-22 的水平降低。这些发现表明,树枝状聚合物可以成为局部基因传递的潜在载体。

相似文献

1
Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.树状聚合物作为一种新型潜在的 siRNA 经皮给药载体:树突状聚合物与脂质体递送 TNF-α siRNA 的比较研究。
Int J Pharm. 2018 Oct 25;550(1-2):240-250. doi: 10.1016/j.ijpharm.2018.08.024. Epub 2018 Aug 27.
2
Preparation, characterization, and evaluation of cyclosporine cationic liposomes for the treatment of psoriasis.环孢菌素阳离子脂质体的制备、表征及治疗银屑病的评价。
J Liposome Res. 2020 Mar;30(1):68-79. doi: 10.1080/08982104.2019.1593449. Epub 2019 Apr 23.
3
Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.利用 PAMAM 树状高分子经肺部传递抗 TNF-α siRNA 治疗小鼠模型中的急性肺炎症。
Eur J Pharm Biopharm. 2020 Nov;156:114-120. doi: 10.1016/j.ejpb.2020.08.009. Epub 2020 Aug 13.
4
Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.载他克莫司和 TNF-αsiRNA 的纳米结构脂质载体作为一种治疗银屑病的新方法。
Drug Deliv Transl Res. 2020 Jun;10(3):646-660. doi: 10.1007/s13346-020-00723-6.
5
Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.负载补骨脂素的脂质体纳米载体可改善皮肤渗透性并提高外用补骨脂素紫外线A光化学疗法治疗银屑病的疗效。
Eur J Pharm Sci. 2017 Jan 1;96:515-529. doi: 10.1016/j.ejps.2016.10.025. Epub 2016 Oct 21.
6
Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.阳离子脂质体和 PAMAM 树枝状聚合物在乳腺癌治疗中递送抗 Plk1 siRNA 的比较。
Pharm Dev Technol. 2020 Jan;25(1):9-19. doi: 10.1080/10837450.2019.1567763. Epub 2019 Oct 31.
7
Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.通过序贯静脉注射阴离子聚合物和 siRNA 的阳离子脂质复合物对肝转移瘤的治疗效果。
J Drug Target. 2016 Apr;24(4):309-317. doi: 10.3109/1061186X.2015.1070856. Epub 2015 Aug 3.
8
Topical delivery of siRNA into skin using SPACE-peptide carriers.使用SPACE肽载体将小干扰RNA经皮递送至皮肤。
J Control Release. 2014 Apr 10;179:33-41. doi: 10.1016/j.jconrel.2014.01.006. Epub 2014 Jan 13.
9
Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification.评价阳离子树状高分子和脂质作为转染试剂对干细胞修饰的短 RNA 效果。
Int J Pharm. 2013 May 1;448(1):231-8. doi: 10.1016/j.ijpharm.2013.03.035. Epub 2013 Mar 25.
10
An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis.一种用于基于RNA干扰的皮肤疾病局部治疗的弹性脂质体制剂:银屑病治疗的概念验证。
Int J Pharm. 2016 Mar 16;500(1-2):268-74. doi: 10.1016/j.ijpharm.2016.01.042. Epub 2016 Jan 19.

引用本文的文献

1
Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments.银屑病:揭示疾病机制与推进药理学和纳米技术治疗
J Inflamm Res. 2025 Feb 10;18:2045-2072. doi: 10.2147/JIR.S506103. eCollection 2025.
2
Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: In vitro and in vivo studies.使用高分子量壳聚糖衍生物将小干扰RNA局部递送至银屑病皮肤模型:体外和体内研究
Drug Deliv Transl Res. 2025 Feb 5. doi: 10.1007/s13346-025-01800-4.
3
Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.
近年来银屑病局部给药系统的研究进展及趋势:综述和文献计量分析。
Int J Nanomedicine. 2024 Jul 29;19:7631-7671. doi: 10.2147/IJN.S461514. eCollection 2024.
4
Nanoparticles and cytokine response.纳米颗粒与细胞因子反应。
Front Bioeng Biotechnol. 2023 Aug 28;11:1243651. doi: 10.3389/fbioe.2023.1243651. eCollection 2023.
5
Biomaterial-based gene therapy.基于生物材料的基因治疗。
MedComm (2020). 2023 Jun 3;4(3):e259. doi: 10.1002/mco2.259. eCollection 2023 Jun.
6
Oncogene Silencing in a Breast Cancer Cell Model Using Cationic Lipid-Based Delivery Systems.使用基于阳离子脂质的递送系统在乳腺癌细胞模型中进行癌基因沉默
Pharmaceutics. 2023 Apr 8;15(4):1190. doi: 10.3390/pharmaceutics15041190.
7
Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models.铜金属树状大分子与传统抗肿瘤药物联合用于体外模型中的癌症治疗。
Int J Mol Sci. 2023 Feb 17;24(4):4076. doi: 10.3390/ijms24044076.
8
Nanoemulgel: A Novel Nano Carrier as a Tool for Topical Drug Delivery.纳米乳凝胶:一种作为局部给药工具的新型纳米载体。
Pharmaceutics. 2023 Jan 3;15(1):164. doi: 10.3390/pharmaceutics15010164.
9
Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics.用于三阴性乳腺癌的隐形脂质体化疗药物,具有改善的药代动力学。
Nanotheranostics. 2022 Aug 21;6(4):424-435. doi: 10.7150/ntno.76370. eCollection 2022.
10
siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.基于 siRNA 的纳米治疗学作为免疫介导性疾病的新兴治疗模式:初步综述。
Cell Biol Int. 2022 Sep;46(9):1320-1344. doi: 10.1002/cbin.11841. Epub 2022 Jul 13.